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Abstract
Cell-penetrating peptides (CPPs) can traverse cellular membranes and deliver biologically active molecules into cells. In this
study, we demonstrate that CPPs comprised of nona-arginine (R9) and a penetration accelerating peptide sequence (Pas)
that facilitates escape from endocytic lysosomes, denoted as PR9, greatly enhance the delivery of noncovalently associated
quantum dots (QDs) into human A549 cells. Mechanistic studies, intracellular trafficking analysis and a functional gene assay
reveal that endocytosis is the main route for intracellular delivery of PR9/QD complexes. Endocytic trafficking of PR9/QD
complexes was monitored using both confocal and transmission electron microscopy (TEM). Zeta-potential and size
analyses indicate the importance of electrostatic forces in the interaction of PR9/QD complexes with plasma membranes.
Circular dichroism (CD) spectroscopy reveals that the secondary structural elements of PR9 have similar conformations in
aqueous buffer at pH 7 and 5. This study of nontoxic PR9 provides a basis for the design of optimized cargo delivery that
allows escape from endocytic vesicles.
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Introduction
The translocation of the transactivator of transcription (Tat)
protein of the human immunodeficiency virus type 1 (HIV-1) into
cells depends on a sequence that contains eleven amino acids
(amino acid sequence: YGRKKRRQRRR) [1]. Using this basic
amino acid-rich sequence as a guide, many small peptides were
designed that possess a similar membrane penetrating potential
[2]. These peptides, dubbed cell-penetrating peptides (CPPs), may
be amphipathic, hydrophobic or cationic [3]. CPPs can facilitate
the delivery of cargoes, including DNAs, RNAs, proteins and
nanoparticles, into living cells [2,4,5]. More than 843 varieties of
CPPs have been catalogued on a CPP site (http://crdd.osdd.net/
raghava/cppsite/) [6].
Although CPPs have recently gained much attention as
powerful tools to introduce exogenous molecules into cells, their
cellular uptake pathways and subsequent intracellular trafficking
are still not fully understood. Studies have suggested that CPPs
utilize multiple pathways for cellular entry [7–9]. Endocytosis and
direct membrane translocation appear to be two major uptake
mechanisms for CPPs. Endocytosis is an energy-dependent
pathway that includes two major categories: phagocytosis involv-
ing uptake of large particles, and pinocytosis involving solute
uptake [7]. Pinocytosis can be further subdivided into macro-
pinocytosis, and clathrin-dependent, caveolin-dependent and
clathrin/caveolin-independent pathways [10]. Endocytosis in-
volves binding to membranes, accumulation in membrane-sunken
vesicles, transfer to early and late endosomes, and fusion to
become late endosomes/lysosomes [11–13]. The progress from
binding to transport into early endosomes can be accomplished
within 30 min [12,13]. Direct membrane translocation, also
known as direct cell penetration, includes a variety of energy-
independent pathways, such as pore formation, inverted micelle
formation, carpet-like alternations and membrane thinning [7,9].
Various physical and pharmacological endocytic inhibitors can be
used to identify pathways of CPP-mediated transduction. For
instance, low temperature (4uC) treatment arrests all energy-
dependent movement across the cell membrane [14]. The
endocytic inhibitor cytochalasin D (CytD), an F-actin polymeri-
zation disrupter, perturbs endocytic processes that involve
clathrin-, caveolae-dependent endocytosis and macropinocytosis
[15,16]. 5-(N-ethyl-N-isopropyl)-amiloride (EIPA) specifically in-
hibits macropinocytosis by inhibiting Na+/H+ exchange proteins
[16,17]. Filipin inhibits lipid raft dependent caveolae endocytosis,
while nocodazole inhibits clathrin-dependent endocytosis [15,16].
The destination of materials internalized by endocytosis is acidic
lysosomes, where proteins and other molecules may be degraded
by hydrolytic enzymes [18].
PLOS ONE | www.plosone.org 1 June 2013 | Volume 8 | Issue 6 | e67100
Since endocytosis is one of the primary membrane translocation
mechanisms of CPPs, escape from endocytic vesicles is essential to
preserve biological activity of endocytosed cargoes [7–9,11].
Chloroquine, a lysosomotropic agent, is commonly used to
circumvent this problem [19,20]. Alternatively, peptides with
certain sequences can be effective. For instance, the penetration
accelerating sequence (Pas) is a synthetic peptide (FFLIPKG)
derived from the cleavable sequence (GKPILFF) of cathepsin D
enzyme, a lysosomal aspartyl protease [21,22]. Addition of Pas to
octa-arginine (R8), denoted as PasR8, enhances the efficiency of
intracellular delivery of bioactive peptides by promoting endoso-
mal escape [21].
Quantum dots (QDs) are colloidal, inorganic nanoparticles with
unique chemical and physical properties [23]. They are excellent
alternatives to fluorescent proteins due to their high photolumi-
nescent quantum efficiency, photostability, tunability, narrow
emission spectral band and prolonged fluorescence lifetime, and
they have been extensively used in various cellular imaging
applications [23–26]. Although QDs can be used to monitor
cellular processes, they enter cells very slowly and become
entrapped in endosomes [25–27]. To overcome these limitations,
surface modified QDs by covalent [28–30] or noncovalent [16,31–
37] linkages with CPPs (referred to as CPP-QD or CPP/QD,
respectively) have been introduced.
The aims of this study were to (1) demonstrate Pas nona-
arginine (PR9)-mediated cellular internalization of QDs, (2)
elucidate the cellular uptake mechanism and subcellular localiza-
tion of PR9/QD complexes, (3) identify the molecular mecha-
nisms of intracellular trafficking of PR9/QD complexes and (4)
identify the physical properties of PR9 and PR9/QD complexes
that affect uptake. To achieve these goals, we synthesized PR9 and
examined transduction pathways and intracellular shuttling of
PR9/QD complexes using flow cytometry and live cell imaging.
To identify the cellular uptake mechanisms of PR9 and PR9/QD
complexes, pharmacological and physical inhibitors were used to
block specific uptake pathways. Transmission electron microscopy
(TEM) was used to monitor endocytic progress. Certain physical
properties of PR9 and PR9/QD complexes were characterized
using zeta-potential analysis and circular dichroism (CD) spec-
troscopy. The toxicity of PR9 and PR9/QD complexes was
assessed using the 1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylforma-
zan (MTT) dye reduction assay. This study provides valuable
mechanistic insights into how PR9s promote escape from
endocytic vesicles and provides a basis for the design of optimized
cargo delivery in cells.
Materials and Methods
Cell Culture
Human lung carcinoma A549 cells (American Type Culture
Collection, Manassas, VA, USA; CCL-185) were maintained in
Roswell Park Memorial Institute (RPMI) 1640 medium (Gibco,
Invitrogen, Carlsbad, CA, USA) supplemented with 10% (v/v)
bovine serum (Gibco) [38].
Preparation of Plasmid DNA, Peptides and Nanoparticles
The pEGFP-N1 plasmid contains the enhanced green fluores-
cent protein (EGFP) coding sequence under the control of the
cytomegalovirus (CMV) promoter (Clontech, Mountain View,
CA, USA) [39,40]. Three arginine-rich CPPs, nona-arginine
(SR9; RRRRRRRRR), histidine-rich nona-arginine (HR9;
CHHHHHRRRRRRRRRHHHHHC), and PR9
(FFLIPKGRRRRRRRRR), were chemically synthesized [33].
CdSe/ZnS QDs (denoted as QDs) with a maximal emission peak
wavelength at 525 nm (carboxyl-functionalized eFluor 525NC)
were purchased from eBioscience (San Diego, CA, USA).
Carboxyl-functionalized InP/ZnS QDs (denoted as QInP) with a
maximal emission peak wavelength at 525 nm were synthesized
[41].
Protein Transduction and Mechanistic Assay
To analyze the kinetics of protein transduction, A549 cells were
seeded at a density of 16105 per 35-mm petri dish and then
incubated overnight in 1 ml of complete growth medium [33]. Six
mM CPPs was mixed with 100 nM QDs (i.e., at a molecular ratio
of 60) at 37uC for 2 h to form CPP/QD complexes. Cells were
washed with 1 ml of phosphate buffered saline (PBS) twice. The
cells were then treated with PBS as a control, 100 nM QDs only,
or CPP/QD complexes in RPMI 1640 medium supplemented
with 1% serum at 37uC for a period of 0–6 h. Cells were washed
with PBS five times to remove free CPP/QD complexes before
analysis.
To determine the cellular uptake mechanism of PR9/QD
complexes, cells were treated with PBS as a negative control,
100 nM QDs alone, or PR9/QD complexes prepared at a
molecular ratio of 60 in RPMI 1640 medium supplemented with
1% serum at 37uC for 30 min in the absence or presence of
various pharmacological and physical inhibitors [16,33]. Cells
were incubated for 30 min at 4uC to arrest energy-dependent
movement across the cell membrane [14], then treated with
100 nM QDs or PR9/QD complexes at 4uC for 30 min. After this
treatment, the cells were washed with PBS twice to remove free
QDs or PR9/QD complexes, followed by flow cytometric analysis.
The influence of modulators on uptake processes was investigated
by treating cells with 100 nM QDs or PR9/QD complexes in the
absence or presence of 100 mM EIPA, 10 mM CytD, 5 mg/ml
filipin, 10 mM nocodazole at 37uC for 30 min. Non-transduced
QDs or PR9/QD complexes were removed from cell surface by
washing with PBS five times. To assess lysosomal escape, cells were
treated with QDs or CPP/QD complexes as described above in
the absence or presence of 25 mM chloroquine for 2 h. Free QDs
or CPP/QD complexes were excluded by washing with PBS five
times before uptake was determined by flow cytometry.
Flow Cytometric Analysis
Cells were seeded at a density of 16105 per well in 24-well
plates and incubated overnight in 500 ml/well of complete culture
medium. Cells in the control and experimental groups treated with
QDs or CPP/QD complexes were harvested and counted using a
Cytomics FC500 flow cytometer (Beckman Coulter, Fullerton,
CA, USA) [33]. To detect green fluorescent proteins (GFP),
excitation was set at 488 nm and emission at 515–545 nm with a
FL1 filter. Data were analyzed using CXP software (Beckman
Coulter). Results are expressed as the percentage of the total cell
population that displays fluorescence.
Subcellular Colocalization Analysis
Endocytic vesicles appear within 30 min, and transport of
vesicles toward lysosomes is completed in approximately 2 h
[12,13]. To examine subcellular localization of the delivered PR9/
QD complexes, cells were treated with 100 nM green fluorescent
QDs alone or CPP/QD complexes in RPMI medium with 1%
serum at 37uC for either 30 min or 2 h. Cells were washed with
PBS five times to remove free CPP/QD complexes, followed by
staining with organelle-specific fluorescent trackers [16,33].
Treatments with organelle trackers included 16.2 mM Hoechst
33342 (Invitrogen; in blue) at 37uC for 40 min, Texas Red-X
phalloidin (Invitrogen; in red) at 37uC for 20 min, 50 nM
Cellular Delivery of Nanoparticles by PR9
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LysoTracker DND-99 (Invitrogen; in red) at 37uC for 30 min,
50 nMMitoTracker Deep Red FM (Invitrogen; in red) at 37uC for
30 min, and 1 mM ER-Tracker Red (Invitrogen; in red) at 37uC
for 30 min to visualize subcellular colocalization with nuclei,
actins, lysosomes, mitochondria and endoplasmic reticula (ER),
respectively. To investigate intracellular trafficking of PR9/QD
complexes, cells were treated with PR9/QD complexes at 37uC
from 30 min to 5 h, and then stained with 1,0006 diluted rabbit
anti-human early endosome antigen 1 protein (EEA1) antibody
and goat Alexa Fluor 647-conjugated anti-rabbit antibody
fragment (Cell Signaling Technology, Danvers, MA, USA) at
37uC for 12 and 2 h, respectively, to visualize subcellular
colocalization with early endosomes.
Confocal and Fluorescent Microscopy
Fluorescent and bright-field live cell images were recorded using
a BD Pathway 435 bioimaging system (BD Biosciences, Franklin
Lakes, NJ, USA) equipped with Olympus 206 and 606 oil
objectives (Olympus, Tokyo, Japan) [33]. This system includes
both confocal and fluorescent microscopy sets. Excitation filters
were set at 377/50 nm, 482/35 nm and 543/22 nm for blue
(BFP), GFP and red (RFP) fluorescent proteins, respectively.
Emission filters were set at 435LP (long-pass), 536/40 nm and
593/40 nm for BFP, GFP and RFP, respectively. Bright-field
microscopy was used to assess cell morphology. Intensities of
fluorescent images were quantified using BD Pathway software
(BD Biosciences).
Intracellular Trafficking of Different PR9/cargo Complexes
A549 cells were seeded at a density of 16104 per well in 96-well
plates. Cells were treated with PR9/QInP complexes prepared at
a molecular ratio of 30 in RPMI 1640 medium supplemented with
1% serum at 37uC from 30 min to 5 h (i.e., all PR9/QD
complexes were prepared at a molecular ratio of 60, while all
PR9/QInP complexes were formed at a molecular ratio of 30).
The solution was then removed, and the cells were washed three
times with PBS. The cells were stained with Hoechst 33342 and
LysoTracker DND-99 followed by observation using a BD
Pathway 435 bioimaging system.
To determine whether PR9 can deliver functional genes, cells
were treated with either 3 mg the pEGFP-N1 plasmid DNA alone
(control) or a pEGFP-N1 plasmid DNA mixed with PR9 (27
nmole) at a nitrogen (NH3
+)/phosphate (PO4
–) (N/P) ratio of 3 in
RPMI 1640 medium supplemented with 1% serum for 30 min to
24 h at 37uC. The solution was then removed, and the cells were
washed three times with PBS. The cells were supplemented with
100 ml full growth medium and incubated at 37uC for 48 h. After
two days, the cells were stained with Hoechst 33342 and observed
using a BD Pathway 435 bioimaging system.
Transmission Electron Microscopy (TEM)
Morphological examination of PR9/QD- and PR9/QD-trans-
duced cells was performed using a Hitachi H-7500 transmission
electron microscope (Hitachi, Tokyo, Japan). PR9/QD complexes
were dropped on Formvar/carbon coated copper grids with 300
mesh and dried at room temperature. Cells were treated with
PR9/QD complexes, washed five times with PBS to remove free
CPP/QD complexes, and then pre-fixed with 2.5% glutaralde-
hyde in 0.1 M phosphate buffer (pH 7.3) for 1 h. The cells were
washed with 0.1 M phosphate buffer twice at a 15-min interval.
The cells were post-fixed with 1% osmium for 1 h and washed
with 5% sucrose. The cells were stained with or without 2% uranyl
acetate, dehydrated in a graded ethanol-acetone series, embedded
in Spurr’s resin (Electron Microscopy Sciences, Hatfield, PA,
USA) [42], and then sliced using a Ultracut-R ultramicrotome
(Leica, Wetzlar, Germany). Finally, the cell sections were
immobilized on single-well copper grids for TEM analysis.
Zeta-potential and Particle Size Measurements
QDs (100 nM), PR9 (6 mM) or PR9/QD complexes at a
molecular ratio of 60 was dissolved in double deionized water at
pH 7 or 5, representing physiological or endosomal conditions,
respectively [43,44]. Each solution was temperature-equilibrated
at 25uC for 2 min in a zeta cell. Sizes and zeta-potentials of
complexes were measured using a Zetasizer Nano ZS and
analyzed using Zetasizer software 6.30 (Malvern Instruments,
Worcestershire, UK) [34,45].
Circular Dichroism (CD) Spectroscopy
Twenty mM PR9 was dissolved in doubly deionized water with
pH 7 or 5 at room temperature. CD spectra of PR9 were analyzed
in a cylindrical quartz cuvette with a 1 mm path-length using a
Jasco J-715 CD spectrometer (Jasco, Easton, MD, USA) at a scan
speed of 50 nm/min [46]. The contents of secondary structures
were calculated using CDPro software.
Cytotoxicity Assay
Cells were seeded at a density of 16104 per well in 96-well
plates and incubated overnight in 200 ml/well of full growth
medium. Cells were treated with PBS as a negative control, treated
with 100% dimethyl sulfoxide (DMSO) as a positive control or
treated with 25 nM–5 mM QInP in RPMI medium with 1%
serum at 37uC for 24 h, washed with PBS, and cultured in full
growth medium at 37uC for 48 h. The cells were treated with
various concentrations of PR9, individual or combinations of
6 mM PR9, 100 nM QDs, 25 mM chloroquine and 15 mM QInP,
as indicated, in RPMI medium with 1% serum at 37uC for 24 h.
The cells were washed with PBS and cultured in full growth
medium at 37uC for 24 h. Cell viability was measured using the
MTT assay [16,47].
Statistical Analysis
Data are expressed as mean 6 standard deviation (SD). Mean
values and SDs were calculated from at least three independent
experiments of triplicates per treatment group. Comparisons
between the control and treated groups were performed by the
Student’s t-test using levels of statistical significance of P,0.05 (*)
and 0.01 (**), as indicated.
Results
PR9 Displays Cellular Internalization at a Relatively
Longer Time
To investigate the efficiency of PR9 mediated transport of QDs
into cells, a time course experiment was conducted in human
A549 cells. QDs were premixed with or without CPPs SR9, HR9
or PR9 for 2 h, added to cells for up to 6 h, and then analyzed by
flow cytometry. At 1 h, the extent of uptake displayed the
following order: HR9/QD . SR9/QD . PR9/QD (Figure 1),
and uptake of all CPP/QD complexes was essentially complete by
4 h. The differences in uptake kinetics may reflect the involvement
of different uptake mechanisms.
Endocytosis is the Main Pathway for Intracellular Delivery
of PR9/QD Complexes
Various pharmacological and physical inhibitors were used to
shed light on the uptake mechanism of PR9/QD complexes. A549
Cellular Delivery of Nanoparticles by PR9
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cells were treated with PBS (negative control), QDs alone or PR9/
QD complexes in the absence or presence of endocytic inhibitors,
followed by flow cytometric analysis. The fraction of cells
containing PR9/QD complexes (positive cells) was reduced to
47.5% by incubation at 4uC, to 66.2% by CytD, to 60.7% by
filipin, and to 71.7% by nocodazole. In contrast, EIPA treatment
(a macropinocytosis inhibitor) did not decrease uptake (Figure 2A).
These results indicate that classical energy-dependent endocytosis
is the major route for cellular internalization of PR9/QD
complexes. To further validate our findings, cells were treated
with QDs or CPP/QD complexes with a lysosomotropic agent
chloroquine. Chloroquine increased the cellular delivery of SR9/
QD and PR9/QD complexes, but not HR9/QD complexes
(Figure 2B). This further supports the notion that cellular
internalization of PR9/QD complexes involves endocytosis.
Colocalization of PR9/QD Complexes with Actin
Filaments and Lysosomes
To determine the subcellular localization of CPP/QD com-
plexes, cells were treated with QDs or CPP/QD complexes and
then stained with organelle-specific fluorescent markers, including
Hoechst 33342, Texas Red-X phalloidin, LysoTracker DND-99,
MitoTracker Deep Red FM and ER-Tracker Red to visualize
nuclei, actins, lysosomes, mitochondria and ER, respectively.
Merged images revealed that some PR9/QD complexes coloca-
lized with actins (Figure 3A) and lysosomes (Figure 3B) at 30 min
and 2 h. SR9/QD complexes colocalized with actins at 2 h
(Figure 3A) and with lysosomes (Figure 3B) at 30 min and 2 h.
HR9/QD complexes did not colocalize with any organelles
examined (Figure 3A–D). Furthermore, CPP/QD complexes were
not associated with mitochondria (Figure 3C), ER (Figure 3D) or
nuclei (Figure 3A–D) at any time. These results indicate that
cellular internalization of PR9/QD complexes involves classical
endocytosis, in agreement with the results presented in Figure 2.
Intracellular Trafficking of Different PR9/cargo Complexes
The data indicate that PR9/QD complexes are endocytosed.
We investigated intracellular trafficking and the fate of the
complexes over a period of five hours using signal colocalization
of fluorescent CPP/QD complexes with organelle-specific mark-
ers.
Cells were treated with PR9/QD complexes for 30 min, 1, 2, 3,
4, and 5 h, followed by staining with anti-human EEA1 antibody,
LysoTracker DND-99 and Hoechst 33342. CPP/QD complexes
and early endosomes showed limited colocalization at 30 min, and
colocalization gradually increased from 1 to 5 h (Figure 4A).
Figure 4B indicates that PR9/QD complexes enter lysosomes (see
insets 1, 2, 3 obtained at 30 min), and most complexes are trapped
in lysosomes at 2–3 h (see insets 1, 2, 3 at 2–3 h). Partially
overlapping images between PR9/QD complexes and lysosomes
were obtained following longer treatments (insets 1–3 obtained at
4 and 5 h of Figure 4B), suggesting an escape of PR9/QD
Figure 1. Time course analysis of CPP-mediated cellular
internalization of QDs. CPPs, including SR9, HR9 and PR9, were
premixed with QDs and then incubated with A549 cells for 0, 0.5, 1, 2, 3,
4, 5 and 6 h. Cellular internalization efficiency was analyzed by flow
cytometry. Cells shown green fluorescence were counted as positive
signals. Data are presented as mean 6 SD from seven independent
experiments.
doi:10.1371/journal.pone.0067100.g001
Figure 2. Mechanism of cellular internalization of PR9/QD
complexes. (A) Cellular uptake of PR9/QD complexes without or with
inhibitors. Cells were treated with PBS as a negative control, QDs alone
or PR9/QD complexes in the absence or presence of endocytic
inhibitors. Low temperature (4uC), 5-(N-ethyl-N-isopropyl)-amiloride
(EIPA), cytochalasin D (CytD), filipin and nocodazole inhibit different
endocytic pathways. Flow cytometry was used to quantitate transduc-
tion efficiency. (B) Effect of the lysosomotropic agent chloroquine on
cellular uptake of CPP/QD complexes. Significant differences at P,0.05
(*) and P,0.01 (**) are indicated. Data are presented as mean 6 SD
from seven (A) and eleven (B) independent experiments.
doi:10.1371/journal.pone.0067100.g002
Cellular Delivery of Nanoparticles by PR9
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Figure 3. Intracellular colocalization of CPP/QD complexes with organelles. A549 cells were treated with QDs alone, SR9/QD, HR9/QD or
PR9/QD complexes for 30 min or 2 h and then stained with Texas Red-X phalloidin for actin filaments (A), LysoTracker DND-99 for lysosomes (B),
MitoTracker Deep Red FM for mitochondria (C) or ER-Tracker Red for endoplasmic reticula (ER) (D). Nuclei were stained with Hoechst 33342. Overlap
of QDs and organelle trackers are yellow in merged GFP and RFP images. Overlaps of QDs and nuclei are cyan in merged GFP and BFP images. All
fluorescent images (A–D) are shown at a magnification of 6006.
doi:10.1371/journal.pone.0067100.g003
Cellular Delivery of Nanoparticles by PR9
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complexes from the acidic vesicles. High green fluorescent
intensity was noticed at the periphery of the nucleus following
the longer incubation, indicating an accumulation of PR9/QD
complexes in this region (GFP channel at 5 h of Figure 4B and 4 h
of Figure 4C). Colocalization intensity of PR9/QD complexes and
lysosomes was maximal following a 2 h incubation, and then
started to decrease (Figure 4B and D), indicating lysosomal escape.
Figure 4C and E show trafficking of PR9/QD complexes
toward nucleus. The complexes spread out near plasma
membrane at an early stage and later condense near the nucleus.
Localization of PR9/QD complexes in the nucleus was observed
from 3 to 5 h (Figure 4B, C and E). Together, these data indicate
that after being endocytosed, CPP/QD complexes move sequen-
tially from endosome to lysosome to cytoplasm to nucleus.
To study intracellular trafficking of different PR9/cargo
complexes, A549 cells were treated with PR9/QInP complexes
for 30 min to 5 h, followed by staining with LysoTracker DND-99
and Hoechst 33342. Trafficking routes of PR9/QInP complexes
were recorded at different times. Merged confocal images reveal a
colocalization of PR9/QInP complexes with lysosomes and
nucleus (Figure 5A). Most PR9/QInP complexes were trapped
in lysosomes at 2 h, but exited the lysosomes and translocated
toward the nucleus at 2–5 h (Figure 5A). To demonstrate delivery
of PR9/cargo complexes to the nucleus, a functional gene assay
was carried out. Cells were treated with pDNA alone or PR9/
DNA complexes for 30 min, 1–5 and 24 h, followed by staining
with Hoechst 33342. After a 24 h incubation, no fluorescence was
detected in the cells treated with pDNA only (Figure 5B). In
contrast, green fluorescence was apparent in cells treated with
PR9/DNA complexes at later times (Figure 5B and C), indicating
that plasmid DNA delivered by PR9s can be expressed. These
results demonstrate that different cargoes delivered by PR9 follow
a similar trafficking pattern in cells. The functional gene assay
confirmed the colocalization of cargoes with the nucleus at a later
stage.
TEM
The morphology of PR9/QD complexes and PR9/QD-
transduced cells was observed using a Hitachi TEM. PR9/QD
complexes were spherical with an average diameter of
2.060.1 nm (Figure 6A left). Electron-dense cores of PR9/QD
complexes were observed associated with the membranes of PR9/
QD-transduced cells following a 30-min incubation (Figure 6A
middle). PR9/QD complexes were observed in a lysosome after a
2-h incubation (Figure 6A right). The endocytic progress of PR9/
QD complexes was indicated by the appearance of labeled
macropinosomes and lysosomes in PR9/QD-transduced cells
(Figure 6B). PR9/QD complexes on the membrane were observed
enclosed in a clathrin-coated pit (Figure 6C), and later enclosed
within a vesicle (early endosome) (Figure 6D). PR9/QD complex-
es-containing macropinosomes, which ultimately fuse with lyso-
somes (Figure 6E), were noted in lamellipodia-like membrane
protrusions (Figure 6F). These results indicate that PR9 transports
QDs into cells by an endocytic pathway.
Zeta-potential, Particle Size Measurements and CD
Spectroscopy
To characterize the physical properties of PR9 and PR9/QD
complexes, zeta-potential, particle size and secondary structure of
PR9 were determined. PR9 and PR9/QD complexes were
Figure 4. Intracellular trafficking of PR9/QD complexes. (A) Trafficking of PR9/QD complexes toward early endosomes. Cells were treated with
PR9/QD complexes for 30 min to 5 h and stained with anti-human early endosome antigen 1 protein (EEA1) antibody. Overlaps of green fluorescent
QDs and red fluorescent early endosomes are yellow in merged GFP and RFP images. (B) Trafficking of PR9/QD complexes toward lysosomes. Cells
were treated with PR9/QD complexes for 30 min to 5 h and stained with LysoTracker DND-99 and Hoechst 33342. (C) Trafficking of PR9/QD
complexes toward the nucleus. A549 cells were treated with PR9/QD complexes for 30 min to 5 h and stained with Hoechst 33342. (D) Time course of
colocalization of PR9/QD complexes with lysosomes. (E) Time course of colocalization of PR9/QD complexes with nuclei. Significant differences at
P,0.05 (*) and P,0.01 (**) are indicated. Data are presented as mean 6 SD from seven independent experiments. Cell morphology is shown as
bright-field images. All fluorescent (A) and confocal images (B and C) are shown at a magnification of 6006.
doi:10.1371/journal.pone.0067100.g004
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analyzed in aqueous solutions at pH 7 (cytosolic condition) and
pH 5 (lysosomal condition). Zeta-potentials of QDs were electro-
negative at pH 7 (225.162.2 mV) and pH 5 (227.361.2 mV)
(Figure 7A); zeta-potentials of arginine-rich PR9 were
14.962.4 mV at pH 7, and 15.663.4 mV at pH 5. PR9/QD
complexes were even more positive: 21.761.1 mV at pH 7 and
17.464.2 mV at pH 5, conditions favoring protein transduction.
On the other hand, PR9/QD complexes were of similar sizes:
16.961.4 and 17.162.6 nm at pH 7 and 5, respectively, while
PR9/QD complexes were larger than QDs (Figure 7B). These
results agree with our recent report that the electrostatic
interactions of CPP/cargo complexes can be a predictor of
transduction efficiency within the charge range tested [48],
emphasizing the significance of zeta-potential for the transduction
of PR9/QD complexes.
Figure 5. Different cargoes delivered by PR9 follow similar trafficking route in cells. (A) Intracellular trafficking of PR9/QInP complexes.
A549 cells were treated with PR9/QInP complexes for 30 min to 5 h and stained with LysoTracker DND-99 and Hoechst 33342. All confocal images are
shown at a magnification of 6006. (B) Functional assay of the PR9-delivered plasmid DNA in cells. Cells were treated with pEGFP-N1 plasmid DNA
alone or PR9/DNA complexes for 24 h followed by the stain with Hoechst 33342. Green fluorescence revealed cells expressing EGFP (only one of
many EGFP-expressing cells is shown here). Blue fluorescence indicates nuclei. Images are shown at a magnification of 2006. (C) Time course of gene
expression for PR9/DNA complexes. Significant differences at P,0.05 (*) are indicated. Data are presented as mean 6 SD from three independent
experiments.
doi:10.1371/journal.pone.0067100.g005
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To determine whether conformational changes of PR9 in acidic
vesicles could be a factor in lysosomal escape, the secondary
structure of PR9 was analyzed using CD spectroscopy. PR9
conformations were very similar at pH 7 and 5 (Figure 7C).
Collectively, these results indicate that zeta-potentials of CPP/QD
complexes are a key factor of transduction efficiency [48],
reflecting the importance of electrostatic interactions of PR9/
QD complexes with plasma membranes and endomembrane
system.
Cytotoxicity
The MTT assay was used to determine the effect of PR9-
mediated cargo delivery on cell viability. Cells were treated with
either individual or a combination of PR9s, QDs, chloroquine and
QInP, as indicated. None of the materials used in this study caused
cytotoxicity (Figure 8), indicating that arginine-rich PR9 would be
a safe vehicle to carry cargo into cells.
Discussion
In this study, we demonstrate that classical energy-dependent
endocytosis is the major route for cellular internalization of PR9/
QD complexes, and that chloroquine exerts a lysosomotropic
effect on PR9/QD complexes, allowing them to escape from
endocytic vesicles into the cytoplasm. PR9/QD complexes
colocalize with actins, lysosomes, early endosomes and nucleus.
TEM analysis revealed the endocytic trafficking of PR9/QD
complexes in cells. A reporter gene assay confirmed that plasmid
DNA delivered by PR9s can be actively expressed by cells [49].
Zeta-potentials of CPP/cargo complexes correlated with trans-
duction efficiency [48], emphasizing the importance of electro-
static interactions of PR9/QD complexes with plasma mem-
branes. Cell viability assay confirmed that none of the components
of the PR9/QD complexes are cytotoxic.
CPP transduction of QDs into stem cells with high transduction
efficiency and low cytotoxicity has been demonstrated [37,50,51].
Moreover, we have shown that PR9 and PR9/cargo complexes
are relatively nontoxic in A549 cells by SRB [33] and MTT
[52,53] assays. Our present results with PR9/QD complexes in
human cells are consistent with these earlier results. It was
reported that more than 80% of adipose tissue-derived stem cells
could be labeled by R8/QD complexes prepared at a ratio of
10,000 within 1 h, and that the consequent fluorescent staining
was maintained at least for 2 weeks [37]. No cytotoxicity was
observed in cells transduced with less than 16 nM of QDs. In
addition, the transduced cells could differentiate into adipogenic
and osteogenic cells, indicating that the transduced cells
maintained their stem cell potency [37].
Research on CPPs has focused on improving transduction
efficiency. The hybrid PasR8 peptide markedly enhanced the
translocation efficiency of active peptides by permitting endosomal
escape in cells [21]. For instance, Pas conjugated with flock house
virus (FHV)-derived arginine-rich peptide was attached to the p53
C-terminal 22-amino-acid peptide (p53C’), a retro-inverso peptide
that induces p53-dependent autophagic cell death [54]. In another
study, the growth of malignant glioma cells was inhibited by the
triplex D-isomer peptides (dPasFHV-p53C’). Recently, the
importance of hydrophobic sequences in the Pas segment,
especially phenylalanine residues, in promoting cellular uptake of
R8 was demonstrated [55]. Attachment of aromatic moieties, such
Figure 6. Transmission electron microscopy (TEM) images of PR9/QD complexes. (A) Images of PR9/QD complexes and PR9/QD-
transduced cells. PR9 peptide was mixed with QDs at a molecular ratio of 60 (left). Cells were treated with PR9/QD complexes; arrows indicate the
location of PR9/QD complexes (middle and right). (B–F) Images of PR9/QD-transduced cells. CCP= clathrin-coated pit, EE = early endosome,
ER = endoplasmic reticulum, Ly = lysosome, Ma=macropinosome, MP=membrane protrusion, Mt =mitochondrium, N= nucleus, PM=plasma
membrane, V = vesicle.
doi:10.1371/journal.pone.0067100.g006
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Figure 7. Zeta-potential and particle size of PR9 and PR9/QD complexes and the secondary structure of PR9. (A) Zeta-potentials of PR9
and PR9/QD complexes. PR9 or PR9/QD complexes prepared at a molecular ratio of 60 were dissolved in doubly deionized water at pH 7 or 5. Each
solution was equilibrated at 25uC for 120 sec in a zeta cell and then analyzed using a Zetasizer Nano ZS. (B) Particle size of QD or PR9/QD complexes.
PR9/QD complexes were dissolved in doubly deionized water with pH 7 or 5 and then analyzed using a Zetasizer. Significant differences between
PR9/QD complexes and QDs at P,0.01 (**) are indicated. Data are presented as mean 6 SD from seven independent experiments. (C) Secondary
structure of PR9. All CD spectra were recorded in millidegree (mdeg).
doi:10.1371/journal.pone.0067100.g007
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as Pas, to a R8 segment may increase peptide-proteoglycan
interactions, thereby stimulating macropinocytosis. PasR8 working
in a serum-containing medium was an additional advantage of the
Pas segment, since serum-binding often decreases cytosolic
internalization of CPPs. The promotion of cellular uptake by
Pas addition is prominent when the molecular weight of cargoes is
relatively small. Finally, the total hydrophobicity of PasR8
conjugates appears to be crucial for efficient cytosolic translocation
[55].
TEM is a valuable tool for the morphological characterization
of biological and nonbiological materials at high resolution [56].
Direct information on the intracellular distribution of transduced
material comes from TEM, which reveals electron-dense cores of
PR9/QD complexes associated with plasma membrane and in the
cytoplasm of PR9/QD-transduced cells (Figure 6). While there are
multiple types of endocytic pathways [15], the endocytic progress
of transport vesicles of the widely studied clathrin-dependent
endocytosis of nanoparticles is from early endosomes to multive-
sicular bodies/late endosomes and finally to lysosomes. TEM
images of PR9/QD-transduced cells obtained in the present study
were generally in accord with this endocytic progression. PR9/QD
complexes were somewhat larger than QDs alone (Figure 7B),
suggesting that positively charged PR9s form stable complexes
with carboxyl-functionalized QDs by electrostatic interactions
[16,33].
Zeta-potential is a useful measure in nanoparticle applications
that indicates the interaction energy on the particle-carrier surface
[57,58]. Zeta-potential depends on nanoparticle size, methods of
production and treatment, surface structure and the pH value of
the environment [37]. The combined effects of both zeta-potential
and particle size on nanoparticles provide insight into the stability
of particles in solution [59,60]. We found that more electropositive
zeta values of CPP/cargo complexes correlate well with protein
transduction efficiency, presumably due to increased electrostatic
interactions of PR9/QD complexes with plasma membranes. In
this study, the more electropositive PR9/QD complexes had a
higher transduction efficiency than PR9s or QDs.
Qualitative secondary structure assignments of CD spectroscopy
were based on the following: minima at both 208 and 222 nm, and
maximum at 190 nm for a-helix; minimum at 218 nm and
maximum at 195 nm for b-sheet; minimum at 198 nm and no
positive peak for random coil [61]. We found that the secondary
structural contents of PR9 have very similar conformations in
aqueous buffers at pH 7 and pH 5 (Figure 7C). These two patterns
(minimum at 198–222 nm and maximum) of PR9 are similar to
those of R9, which is mostly unstructured in solution [62]. Binding
of poly-L-arginine composed of 293 (PLA239) and 554 (PLA554)
arginine-residues to an anionic phospholipid large unilamellar
vesicle (LUV) was accompanied by a transition from random coil
to a-helix structure; however, a similar structural change was not
observed with PLA69 and R8 [63].
Subcellular colocalization analyses revealed that HR9/QD
complexes do not colocalize with any organelles tested; these
complexes stay in the cytosol most of time (Figure 3). This result is
consistent with our earlier demonstration that HR9/QD com-
plexes enter cells by direct membrane translocation [33,34]. In
contrast, endocytosis appears to be the main route for intracellular
delivery of PR9/QD and SR9/QD complexes [34]. However,
SR9/QD complexes entered cells by multiple pathways [64].
Among them, macropinocytosis, a lipid raft-dependent form of
endocytosis, is a prominent route for SR9/QD entry [65]. Actin
forms microfilaments, one of key components of the cytoskeleton,
participating in many cellular processes, including endocytosis.
Macropinocytosis and classical endocytosis, such as clathrin-,
caveolae-dependent, and clathrin- and caveolae-independent
pathways, involve actin rearrangements. Therefore, the observed
colocalization of PR9/QD with actin, lysosomes and early
endosomes, indicates that these complexes enter cells through an
endocytic pathway.
Numerous factors, including experimental conditions, physico-
chemical properties of CPPs and their cargoes, cell type,
temperature and serum level in the medium can influence the
pathway of cellular uptake [7,11,66–70]. R9, antennapedia
peptide and Tat peptide use a combination of three endocytic
pathways: macropinocytosis, clathrin-mediated endocytosis and
Figure 8. Cytotoxicity of materials used for cargo delivery by PR9 as determined using the MTT assay. Cells were treated with QD, PR9,
chloroquine, PR9/QD, QD/chloroquine, PR9/QD/chloroquine, QInP alone and PR9/QInP complexes for 24 h. Significant differences at P,0.05 (*) and
P,0.01 (**) are indicated. Data are presented as mean 6 SD from three independent experiments.
doi:10.1371/journal.pone.0067100.g008
Cellular Delivery of Nanoparticles by PR9
PLOS ONE | www.plosone.org 10 June 2013 | Volume 8 | Issue 6 | e67100
caveolae/lipid-raft-mediated endocytosis [66]. It seems likely that
PR9s use the same three endocytic pathways (Figure 2A and 3–6).
The chemical properties of the cargo molecules are a contributing
factor of dodeca-arginine (R12) peptide-mediated translocation
[69]. R12 attached to hydrophobic cargoes stimulate dynamic
morphological alternations in plasma membranes, and these
structural changes allow R12 to permeate plasma membranes
[69].
Conclusions
PR9/QD complexes comprised of a cell penetrating peptide
(nona-arginine; R9) and a peptide penetration accelerating
sequence (Pas) that promotes lysosomal escape noncovalently
complexed with a quantum dot (QD) probe were evaluated as a
cell transduction system. Histological results demonstrate that
endocytosis is the main pathway for cellular uptake of PR9/QD
complexes. PR9/QD complexes initially colocalize with actins,
lysosomes and early endosomes, and later with the nucleus.
Plasmid DNA delivered by PR9s was expressed by cells. Zeta-
potential analysis revealed the importance of electrostatic interac-
tions of PR9/QD complexes with plasma membranes. PR9/QD
complexes were not toxic to the cells. Thus, PR9 may be an
efficient and safe delivery vector for biomedical applications.
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